Psychemedics Analysis

Psychemedics is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Psychemedics pink sheet analysis is to determine its intrinsic value, which is an estimate of what Psychemedics is worth, separate from its market price. There are two main types of Psychemedics' stock analysis: fundamental analysis and technical analysis.
The Psychemedics pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Psychemedics' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Psychemedics Pink Sheet Analysis Notes

About 23.0% of the company outstanding shares are owned by corporate insiders. The book value of Psychemedics was at this time reported as 1.15. The company recorded a loss per share of 0.51. Psychemedics last dividend was issued on the 24th of May 2023. The entity had 1:4 split on the 1st of August 2002. Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts. Psychemedics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 1 people.The quote for Psychemedics is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Psychemedics contact Raymond Kubacki at 800 527 7424 or learn more at https://www.psychemedics.com.

Psychemedics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Psychemedics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Psychemedics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Psychemedics is not yet fully synchronised with the market data
Psychemedics has some characteristics of a very speculative penny stock
Psychemedics has a very high chance of going through financial distress in the upcoming years
The company reported the last year's revenue of 22.1 M. Reported Net Loss for the year was (4.15 M) with profit before taxes, overhead, and interest of 9.29 M.
Psychemedics has about 1.79 M in cash with (1.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32.
Roughly 23.0% of the company outstanding shares are owned by corporate insiders

Psychemedics Upcoming and Recent Events

19th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

Psychemedics Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 15.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Psychemedics's market, we take the total number of its shares issued and multiply it by Psychemedics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Psychemedics Profitablity

The company has Net Profit Margin of (0.22) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.19) %, which entails that for every $100 of revenue, it lost $0.19.

Psychemedics Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Psychemedics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Psychemedics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Psychemedics insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Powell Anderson Capital Partners Llc over three months ago
Acquisition by Powell Anderson Capital Partners Llc of 30000 shares of Psychemedics at 1.97 subject to Rule 16b-3
 
Powell Anderson Capital Partners Llc over three months ago
Acquisition by Powell Anderson Capital Partners Llc of 80000 shares of Psychemedics at 1.88 subject to Rule 16b-3
 
Powell Anderson Capital Partners Llc over three months ago
Acquisition by Powell Anderson Capital Partners Llc of 75000 shares of Psychemedics at 2.67 subject to Rule 16b-3
 
Powell Anderson Capital Partners Llc over three months ago
Acquisition by Powell Anderson Capital Partners Llc of 4518 shares of Psychemedics at 2.71 subject to Rule 16b-3
 
Kamin Peter over three months ago
Acquisition by Kamin Peter of 1409712 shares of Psychemedics at 2.35 subject to Rule 16b-3
 
Kamin Peter over three months ago
Acquisition by Kamin Peter of 627 shares of Psychemedics at 6.52 subject to Rule 16b-3
 
Weinert Fred J over six months ago
Disposition of 1000 shares by Weinert Fred J of Psychemedics subject to Rule 16b-3
 
Kamin Peter over six months ago
Discretionary transaction by Kamin Peter of tradable shares of Psychemedics subject to Rule 16b-3
 
Shoemaker Shannon over a year ago
Psychemedics exotic insider transaction detected
 
Weisenhoff Michael over a year ago
Acquisition by Weisenhoff Michael of 4000 shares of Psychemedics subject to Rule 16b-3
 
Weisenhoff Michael over a year ago
Psychemedics exotic insider transaction detected
 
Michael Schaffer over a year ago
Payment of 375 shares by Michael Schaffer of Psychemedics subject to Rule 16b-3

Psychemedics Outstanding Bonds

Psychemedics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Psychemedics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Psychemedics bonds can be classified according to their maturity, which is the date when Psychemedics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Psychemedics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Stock Tickers Now

   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
All  Next Launch Module
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Consideration for investing in Psychemedics Pink Sheet

If you are still planning to invest in Psychemedics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Psychemedics' history and understand the potential risks before investing.
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.